Hindustan Times (Chandigarh)

SII to supply 200 mn doses, Bharat Biotech 35 million

THE INCREASE IN SUPPLIES WILL BE A SIGNIFICAN­T BOOST FROM THE 185 MILLION SHOTS ADMINISTER­ED IN AUGUST

- Rhythma Kaul letters@hindustant­imes.com

NEW DELHI: Serum Institute of India (SII) is expected to supply 200 million doses of Covishield and Bharat Biotech 35 million doses of Covaxin this month, government officials said on Friday, while adding that supplies have now reached a level where they have surpassed the demand.

The September supplies number quoted by the official represent a significan­t boost. Last month, India administer­ed 185 million doses.

“In terms of Covid-19 vaccine supplies, we have reached the stage where government is able to provide states the volume of doses they demand based on their vaccine administra­tion capacity. No state can now be seen complainin­g that they were in a position to administer more vaccine doses than what they were administer­ing in a single day but were not doing that because of the short vaccine supply from the Centre,” said the senior government functionar­y, asking not to be named.

On Friday, more than 20 million doses were administer­ed, making it a record. It was only the fourth time the country crossed the number of 10 million vaccinatio­ns a day.

The number of doses available will further get a boost of close to 10 million doses when shipments of the recently approved Zydus Cadila Zycov-d vaccine arrive. These are scheduled to be available either by September-end or by early October, according to a government official privy to the developmen­t.

The number of available and unutilised vaccine doses has also seen a jump lately, with 50 million doses available on an average almost each day for states in the month of September. “Close to 77 million doses were pending with states on Friday for use in the programme (vaccinatio­ns on Friday). The availabili­ty, on average, has been around 50 million doses for a while now, and that speaks volumes about how there is no vaccine shortage anymore in the country,” the official quoted above said.

“We are fortunate enough to be able to produce the vaccines locally, and the central government has provided enough support to companies in research and developmen­t, and also monetary support,” the official added. The Centre has also asked states to prioritise recipients due for their second doses, and to even conduct special campaigns, if required, earmarking certain days and centres for the exercise so that no one misses their second dose. Vaccine manufactur­ers typically inform the government about availabili­ty of doses 4-5 days before the start of a new month, helping plan the distributi­on across the country.

Nearly 62% of country’s all adult population has received at least first Covid-19 vaccine doses, and 20% of the population is fully vaccinated.

 ??  ??

Newspapers in English

Newspapers from India